Raydiant Oximetry
PrivateLast Round
Grant
Nov 1, 2024
Total Funding Raised
$30.45M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Raydiant Oximetry is a medical technology company that develops non-invasive fetal pulse oximetry sensors to monitor fetal oxygen levels during labor and delivery.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Sensors
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Raydiant Oximetry Comparables
Compare Raydiant Oximetry with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Storx Technologies | 93% | |
| Walela | 85% | |
| Wavelet Medical | 82% |
Raydiant Oximetry Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Nov 1, 2024 | ||||
| Grant | Sep 24, 2024 | ||||
| Series A Extension | Jun 4, 2024 | ||||
| Series B | Feb 7, 2023 | ||||
| Series A Extension | Nov 2, 2021 | ||||
Grant | May 26, 2021 |
Key People
Founding team and executive leadership
Raydiant Oximetry Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Institute of Biomedical Imaging and Bioengineering | Grant |
| KOFA Healthcare | Series A Extension |
| March of Dimes | Series B, Series A Extension |
| SteelSky Ventures | Series A Extension |
| Avestria Ventures | Series A, Series A Extension |
| Gates Foundation | Grant |
| Tara Health Foundation | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 42% MoM, from 807 to 1.1K.
- Nov 1, 2024
$750K grant received from multiple foundations and institutes.
Raydiant Oximetry Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Raydiant Oximetry's valuation, stock price, and market status.
Is Raydiant Oximetry a public or private company?
Raydiant Oximetry is a private company.
What is the current stock price of Raydiant Oximetry?
Raydiant Oximetry is a private company with no public stock price. No recent secondary market data is available.
How much is Raydiant Oximetry worth (valuation)?
Valuation information for Raydiant Oximetry is not publicly available.
Can I buy Raydiant Oximetry stock?
Raydiant Oximetry shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Raydiant Oximetry's last funding round?
Raydiant Oximetry's most recent funding round was Grant on November 1, 2024.
Who are the main investors in Raydiant Oximetry?
Key investors in Raydiant Oximetry include Avestria Ventures, Cross Border Impact Ventures, VCapital.
Will Raydiant Oximetry IPO soon?
No public IPO plans have been announced for Raydiant Oximetry.
How can I track Raydiant Oximetry secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Raydiant Oximetry's secondary market activity and sign up for updates.